CME unveils term SOFR in face of ARRC doubts

Tweet
Facebook
LinkedIn
Save this article
Send to
Print this page

CME has forged ahead with its term version of SOFR – the official replacement for US dollar Libor – just a month after a regulator-backed working group said it would not be able to endorse such a rate before year-end.

The Alternative Reference Rates Committee, which is tasked with weaning US markets off Libor, last month pushed back its planned June 2021 endorsement of a term SOFR benchmark. It argued the rate would not be robust as there was not enough volume in the derivatives that would

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to print this content. Please contact [email protected] to find out more.

You are currently unable to copy this content. Please contact [email protected] to find out more.

You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email [email protected]

You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email [email protected]